Good morning to everyone:
unusual_whales: BREAKING: Now this is unusual.
Just before UniQure, $QURE, announced it was seeking FDA approval for Huntington’s disease gene therapy, there was huge unusual $QURE $35 calls, expiring 07/17/2026.
$QURE went up 78%.
These traders made huge gains.
Unusual.
The post highlights unusual options trading activity for UniQure ($QURE) just before the company announced it was seeking FDA approval for its Huntington’s disease gene therapy, which led to a 78% surge in the stock price.
The author is reporting on a past event where unusual options activity preceded a 78% surge in the stock price due to FDA approval news. The post points out potential insider trading rather than providing a forward-looking investment thesis. External data confirms the 78.4% price jump and the news regarding the FDA's stance on its Huntington's BLA, aligning with the post's factual statements.
关键要点
Unusual $35 call options expiring on 07/17/2026 were purchased right before a major FDA-related announcement.
$QURE announced it is seeking FDA approval for its Huntington’s disease gene therapy.
The stock price surged by 78% following the news, resulting in massive gains for the options traders.
